Login / Signup

Unraveling the miRNA Puzzle in Atherosclerosis: Revolutionizing Diagnosis, Prognosis, and Therapeutic Approaches.

Ahmed I AbulsoudShereen Saeid ElshaerNehal I RizkReem KhaledAmr M AbdelfatahAhmed M AboelyazedAly M WaseemDoha BashierOsama A MohammedMohammed S ElballalSherif S Abdel MageedMahmoud A ElrebehyMohamed Bakr ZakiAhmed E ElesawyWalaa A El-DakrouryMustafa Ahmed Abdel-ReheimSameh SaberAhmed S Doghish
Published in: Current atherosclerosis reports (2024)
Recent research has demonstrated that miRNAs have a regulatory function in the observed changes in gene and protein expression during atherogenesis, the process that leads to atherosclerosis. Several miRNAs play a role in the development of atherosclerosis, and these miRNAs could potentially serve as non-invasive biomarkers for atherosclerosis in various regions of the body. These miRNAs have the potential to serve as biomarkers and targets for early treatment of atherosclerosis. The start and development of AS require different miRNAs. It reviews new research on miRNAs affecting endothelium, vascular smooth muscle, vascular inflammation, lipid retention, and cholesterol metabolism in AS. A miRNA gene expression profile circulates with AS everywhere. AS therapies include lipid metabolism, inflammation reduction, and oxidative stress inhibition. Clinical use of miRNAs requires tremendous progress. We think tiny miRNAs can enable personalized treatment.
Keyphrases